Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Bonnie Ky, MD, MSCE

Associate Professor of Medicine
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
11-105 Smilow Center for Translational Research
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-573-6606
Fax: 215-746-7415
Education:
BS (Chemical Engineering )
Massachusetts Institute of Technology, 1995.
MD (Medicine)
University of Pennsylvania, 2001.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2009.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of CVI Expertise

Cardiotoxicity from cancer therapy is detectable, preventable and treatable. This is the focus of Dr. Ky’s research program. Cancer therapies are becoming increasingly effective at killing cancer, but these treatments also have toxic side effects, resulting in a growing population of cancer patients and survivors with heart disease. In our lab, we are studying innovative strategies to understand the changes in heart function that occur with common cancer therapies, and how we can apply these methods to understand an individual patient’s risk of developing heart disease and heart failure. Our goals are to bring these exciting research findings to the clinic and continue our mission of delivering state-of-the-art, evidence-based medicine to cancer patients and survivors regionally and nationally. We highlight 3 recent discoveries from our lab below.

How breast cancer therapy affects heart function. In a recent paper published in Circulation, we rigorously and comprehensively define the precise changes that occur with heart function over time in breast cancer patients treated with doxorubicin, trastuzumab and radiation. We found that with these cancer therapies, there are modest, but persistent declines in heart function, even at 3 years post treatment exposure. We also determined that afterload, or blood pressure, is a major determinant of this adverse remodeling. These findings might suggest that aggressive blood pressure control is critical in mitigating a patient’s risk of developing heart dysfunction. We have proposed new trials to test this hypothesis.

How innovative new imaging tools can predict heart damage with cancer therapy. We are also interested in discovering new strategies to predict the risk of subsequent heart damage in cancer patients. In two separate manuscripts published in the Journal of American College of Cardiology Imaging, we have used 2-dimensional and 3-dimensional ultrasound techniques in order to more precisely and deeply understand how the heart functions. We have discovered that early changes in 2D and 3D circumferential strain, or deformation, are associated with the risk of developing cardiotoxicity with anthracyclines.

How simple blood tests – using new markers – can predict heart damage with cancer therapy. We are also studying the role of new blood markers of oxidative stress – and how they can predict who will develop heart damage with anthracycline chemotherapy. These findings were published in the Journal of the American College of Cardiology. We are now testing in a clinical trial how these blood markers can be used to understand why statins might protect the heart and who may benefit the most from statins when receiving anthracycline chemotherapy.

Selected Publications

DiLorenzo MP, Wang Y, Ky B, Elci O, Goldmuntz E, Mercer-Rosa L: Longitudinal Changes in Right Ventricular Function in Tetralogy of Fallot in the Initial Years after Surgical Repair Journal of the American Society of Echocardiography 31(7): 816-821, July 2018.

Brown J, Damjanov N, Courneya KS, Troxel A, Zemel B, Rickels MR, Ky B, Rhim A, Rustgi A, Schmitz K : A Randomized Dose-Response Trial of Aerobic Exercise and Health-Related Quality of Life in Colon Cancer Survivors. Pscyho-Oncology 27(4): 1221-1228, April 2018.

Catino AB, Hubbard RA, Chirinos JA, Townsend R, Keefe S, Haas NB, Puzanov I, Fang JC, Agarwal N, Hyman D, Smith AM, Gordon M, Plappert T, Englefield V, Narayan V, Ewer S, Elamm C, Lenihan DJ, Ky B: Longitudinal Assessment of Vascular Function with Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Circulation Heart Failure 11(3): e004408, March 2018.

Zhang KW, Finkelman BS, Gulati G, Narayan HK, Upshaw J, Narayan V, Plappert T, Englefield V, Smith AM, Zhang C, Hundley WG, Ky B: Abnormalities in Three-Dimensional Left Ventricular Mechanics with Anthracycline Chemotherapy are Associated with Systolic and Diastolic Dysfunction. Journal of the American College of Cardiology Imaging March 2018 Notes: epub ahead of print.

Waxman AJ, Clasen S, Hwang WT, Garfall A, Vogl DT, Carver J, O'Quinn R, Cohen AD, Stadtmauer E, Ky B, Weiss BM.: Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-Analysis. JAMA Oncology 4(3): e174519, March 2018.

Zhao H, O’Quinn R, Ambrose M, Jagasia D, Ky B, Wald J, Ferrari V, Kirkpatrick J, and Han Y: Contrast Echocardiography Provides the Greatest Impact in Patients with Reduced Ejection Fraction. Journal of the American Society of Echocardiography 31(3): 289-296, March 2018 Notes: epub ahead of print.

Khouri MG, Ky B, Dunn G, Plappert T, Englefield V, Rabineau D, Yow E, Barnhart HX, St John Sutton M, Douglas PS : Echocardiography Core Lab Reproducibility of Cardiac Safety Assessments in Cardio-Oncology. Journal of the American Society of Echocardiography 31(3): 361-373, March 2018 Notes: Epub 2018 Feb 2.

Brown J, Rickels M, Troxel A, Zemel B, Damjanov N, Ky B, Rhim A, Rustgi A, Courneya KS, Schmitz K: Dose-response Effects of Exercise on Insulin Among Colon Cancer Survivors. Endocrine Related Cancer 25(1): 11-19, Jan 2018.

DiLorenzo MP, Hwang WT, Goldmuntz E, Ky B,* Mercer-Rosa L* (*co senior authors): Diastolic Dysfunction in Tetralogy of Fallot: Comparison of Echocardiography with Catheterization. Echocardiography 2018 Notes: Manuscript accepted.

Schaffer K, Panneerselvam N, Loh KP, Herrmann R, Kleckner I, Dunne RF, Lin P, Heckler CE, Gerbino N, Bruckner LB, Storozynsky Ky B, Mohile SG, Mustian KM, Fung C: A Systematic Review of Randomized Controlled Trials of mHealth Exercise Interventions in Cancer Patients During and After Treatments. Journal of the National Comprehensive Cancer Network A Systematic Review of Mobile Health Exercise Interventions in Patients with Cancer 2018 Notes: Manuscript accepted.

back to top
Last updated: 08/28/2018
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration